0001493152-19-000041.txt : 20190102 0001493152-19-000041.hdr.sgml : 20190102 20190102170027 ACCESSION NUMBER: 0001493152-19-000041 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190102 DATE AS OF CHANGE: 20190102 EFFECTIVENESS DATE: 20190102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Propanc Biopharma, Inc. CENTRAL INDEX KEY: 0001517681 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300662986 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-329457 FILM NUMBER: 19502406 BUSINESS ADDRESS: STREET 1: 302/6 BUTLER STREET CITY: CAMBERWELL, VICTORIA STATE: C3 ZIP: 3124 BUSINESS PHONE: 613-9882-6723 MAIL ADDRESS: STREET 1: 302/6 BUTLER STREET CITY: CAMBERWELL, VICTORIA STATE: C3 ZIP: 3124 FORMER COMPANY: FORMER CONFORMED NAME: Propanc Health Group Corp DATE OF NAME CHANGE: 20110408 D 1 primary_doc.xml X0708 D LIVE 0001517681 Propanc Biopharma, Inc. 302, 6 BUTLER STREET CAMBERWELL, VIC C3 AUSTRALIA 3124 310-402-2681 DELAWARE Propanc Health Group Corporation Propanc Health Group Corp Corporation true James Nathanielsz 302, 6 Butler Street Camberwell, VIC C3 AUSTRALIA 3124 Executive Officer Director Julian Kenyon 302, 6 Butler Street Camberwell, VIC C3 AUSTRALIA 3124 Director Biotechnology Decline to Disclose 06b false 2018-11-30 false true true Convertible promissory note false 0 105000 105000 0 false 1 0 0 0 Some proceeds to be used for general working capital purposes may include salaries and payments to officers and/or directors listed in Item 3. false Propanc Biopharma, Inc. /s/ James Nathanielsz James Nathanielsz CEO and CFO 2019-01-02